🔎 Trials Near Me

Beranda › Kanker (semua jenis) › Minnesota

Uji klinis Kanker (semua jenis) di Minnesota

50 studi untuk Kanker (semua jenis) mencari peserta di lokasi di Minnesota.

Kota di Minnesota

Teks studi resmi (Bahasa Inggris)

A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism

  • Investigative Site, Rochester
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT06881992

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

  • Mayo Clinic Rochester, Rochester
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT04981119

A Study of JNJ-1761981 in Participants With Solid Tumors

  • Mayo Clinic Rochester, Rochester
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07525141

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

  • Mayo Clinic Cancer Center Outpatient Pharmacy, Rochester
  • Mayo Clinic, Rochester
Menerima pesertaFase 2/3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06989437

A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer

  • Metro Minnesota Community Oncology Research Consortium (MMCORC), Saint Louis Park
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06901531

A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

  • Minnesota Oncology - Edina Clinic /ID# 280698, Edina
  • Mayo Clinic Hospital Rochester /ID# 279784, Rochester
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT07365241

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

  • M Health Fairview University of Minnesota Medical Center - East Bank, Minneapolis
  • Mayo Clinic, Rochester
Menerima pesertaFase 2/3
Semua usia · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT03435796

Connect for Cancer Prevention Study (Connect)

  • HealthPartners, Minneapolis
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 30 hingga 70 · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT04609072

Statins to Prevent Cancer Associated Blood Clots

  • Mayo Clinic, Rochester
Menerima pesertaFase 4
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT07303816

Biomarkers of Resiliency In Childhood Cancer Surgery

  • Mayo Clinic, Rochester
Menerima pesertaStudi observasional
Usia 3 hingga 25 · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT06674811

A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies

  • Mayo Clinic Rochester, Rochester
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT06634589

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  • Allina Health Cancer Institute - Abbott Northwestern Hospital, Minneapolis
  • HealthPartners Cancer Research Center, Saint Paul
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT06119581

A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)

  • Mayo Clinic Rochester, Rochester
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT06163534

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

  • Mayo Clinic-Comprehensive Cancer Center-Breast Clinic, Rochester
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT06072612

Project: Every Child for Younger Patients With Cancer

  • Children's Hospitals and Clinics of Minnesota - Minneapolis, Minneapolis
  • University of Minnesota/Masonic Cancer Center, Minneapolis
  • Mayo Clinic in Rochester, Rochester
Menerima pesertaStudi observasional
Hingga usia 25 · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT02402244

Abatacept in Immune Checkpoint Inhibitor Myocarditis

  • Mayo Clinic, Rochester
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 20 Agu 2026 · NCT05335928

FOG-001 in Locally Advanced or Metastatic Solid Tumors

  • M Health Fairview University of Minnesota Medical Center, Minneapolis
  • Mayo Clinic, Rochester
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Agu 2026 · NCT05919264

A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer

  • University of Minnesota Hospital, Minneapolis
Menerima pesertaFase 2
Usia 1 hingga 39 · Semua jenis kelamin · Diperbarui 7 Agu 2026 · NCT05999994

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

  • Riverwood Healthcare Center, Aitkin
  • Essentia Health - Baxter Clinic, Baxter
  • Sanford Joe Lueken Cancer Center, Bemidji
  • dan 48 lainnya
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 7 Agu 2026 · NCT06580314

A Study of ASP1002 in Adults for Treatment of Solid Tumors

  • HealthPartners Cancer Research Center, Saint Paul
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Jul 2026 · NCT05719558

Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers

  • 518, Minneapolis
Menerima pesertaFase 2
Usia 18 ke atas · Wanita · Diperbarui 16 Jul 2026 · NCT06906341

Capturing Food Intake in Patients Undergoing Radiation Therapy for Cancer

  • University Of Minnesota, Minneapolis
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Jul 2026 · NCT07682714

A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma

  • Mayo Clinic - Rochester /ID# 251164, Rochester
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Jul 2026 · NCT05650632

A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease

  • Scri Minnesota Oncology Hematology, P.A. /ID# 275149, Minneapolis
  • Mayo Clinic-Rochester /ID# 273508, Rochester
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Jul 2026 · NCT07023289

Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer

  • Allina Health, Virginia Piper Cancer Institute, Coon Rapids
  • Virginia Piper Cancer Institute Mercy Hospital-Unity Campus, Fridley
  • VPCI Oncology Research, Minneapolis
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Jul 2026 · NCT05181826

A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

  • Mayo Clinic, Rochester
Menerima pesertaFase 1
Usia 18 ke atas · Pria · Diperbarui 9 Jul 2026 · NCT07103018

A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)

  • GSK Investigational Site, Minneapolis
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Jun 2026 · NCT06431594

Childhood Cancer Survivor Study

  • Children's Hospitals & Clinics of Minnesota, Minneapolis
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Semua usia · Semua jenis kelamin · Diperbarui 17 Jun 2026 · NCT01120353

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

  • Mayo Clinic Rochester, Rochester
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 12 Jun 2026 · NCT06051695

Patient Derived Preclinical Models

  • Mayo Clinic in Rochester, Rochester
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Jun 2026 · NCT05324553

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

  • Children's Hospital and Clinics of Minn, Minneapolis
Menerima pesertaFase 1/2
12 Months – 30 Years · Semua jenis kelamin · Diperbarui 19 Mei 2026 · NCT04901702

The Sarah Nanotechnology System for Treatment of Advanced Metastatic Solid Tumors Using Hyperthermia.

  • Mayo Clinic, Rochester
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Mei 2026 · NCT07224464

A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid Tumors

  • Mayo Clinic Rochester, Rochester
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Mei 2026 · NCT05954312

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

  • University of Minnesota, Minneapolis
  • Mayo Clinic, Rochester
  • Metro Minnesota Community Oncology Research Consortium, Hennepin County Medical Center, Saint Louis Park
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 6 Mei 2026 · NCT01042379

Axelopran for Advanced Cancer in Patients Receiving Opioids

  • HealthPartners Frauenshuh Cancer Research Center, Saint Louis Park
  • HealthPartners Cancer Center at Regions Hospital, Saint Paul
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Mei 2026 · NCT07354919

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

  • Mayo Clinic, Rochester
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Apr 2026 · NCT03328078

INTERogating Cancer for Etiology, Prevention and Therapy Navigation

  • Mayo Clinic in Rochester, Rochester
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 7 Apr 2026 · NCT06008392

Multi-Cancer Detection Observational Cohort Study

  • Mayo Clinic in Rochester, Rochester
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 21 ke atas · Semua jenis kelamin · Diperbarui 6 Apr 2026 · NCT06962995

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.